Cat. No. | Product Name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T14990 | CDK12-IN-3
化合物 T14990
|
2220184-50-7 | 98% |
|
CDK12-IN-3 is a selective CDK12 inhibitor (IC50: 491 nM in an enzymatic assay). | ||||
T10546 | Bio-THZ1
化合物 T10546
|
1604811-14-4 | 98% |
|
bio-THZ1 is a biotinylated version of THZ1. THZ1 is a selective and irreversibly covalent CDK7 inhibitor (IC50: 3.2 nM). | ||||
T13153 | THZ1-R
化合物 T13153
|
1621523-07-6 | 98% |
|
THZ1-R displays diminished activity for CDK7 inhibition(Kd:142 nM). | ||||
T12355 | Palbociclib-d8
化合物 T12355
|
1628752-83-9 | 98% |
|
Palbociclib D8 is a deuterium labeled Palbociclib. Palbociclib is a selective and orally active inhibitor of CDK4 and CDK6 (IC50s of 11 and 16 nM, respectively).... | ||||
T10382 | AS2863619 free base
化合物 T10382
|
2241300-50-3 | 98% |
|
AS2863619 free base enables the conversion of antigen-specific effector/memory T cells into Foxp3+ regulatory T (Treg) cells. It is a potent, orally active CDK8 ... | ||||
T13202L | Trilaciclib
化合物 T13202L
|
1374743-00-6 | 98% |
|
Trilaciclib is an inhibitor of CDK4/6 (IC50s: 1 nM and 4 nM for CDK4 and CDK6, respectively). | ||||
TL0017 | Aristolactam AIIIa
化合物 TL0017
|
97399-91-2 | 98% |
|
Aristolactam AIIIa is a new type of Plk1 inhibitors, targeting the Polo Box domain (PBD), it has anti-tumor activity. Aristolactam IIIa shows inhibition of plate... | ||||
T10464 | Atuveciclib
化合物 T10464
|
2923012-24-0 | 98% |
|
Atuveciclib (BAY-1143572) 是一种有效且高度选择性的口服 PTEFb/CDK9抑制剂。Atuveciclib (BAY-1143572) 抑制 CDK9/CycT1,IC50为 13 nM。 | ||||
TN1728 | Hellebrigenin
蟾蜍它里定
|
465-90-7 | 98% |
|
Hellebrigenin has anti-hepatoma activities, it induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells through inhibition of Akt. H... | ||||
T15731 | Ribociclib succinate hydrate
化合物 T15731
|
1374639-79-8 | 98% |
|
Ribociclib succinate hydrate is a highly specific CDK4/6 inhibitor (IC50s: 10 nM and 39 nM, respectively). It also is over 1,000-fold less potent against the cyc... | ||||
TN3673 | Clausine Z
化合物 TN3673
|
866111-14-0 | 98% |
|
Clausine Z exhibits inhibitory activity against cyclin-dependent kinase 5 (CDK5) and shows protective effects on cerebellar granule neurons in vitro. | ||||
T11655 | Indomethacin-D4
吲哚美辛-D4
|
87377-08-0 | 98% |
|
Indomethacin-D4 is a deuterium labeled Indomethacin. Indomethacin is a potent and nonselective inhibitor of COX1 and COX2, with IC50s of 18 nM and 26 nM for huma... | ||||
T10465 | Atuveciclib S-Enantiomer
化合物 T10465
|
2250279-81-1 | 98% |
|
Atuveciclib S-Enantiomer (BAY-1143572 S-Enantiomer) 是 BAY-1143572的 S-对映异构体 ,是一种有效的选择性 CDK9抑制剂,抑制 CDK9/CycT1,IC50为 16 nM。 | ||||
T10836 | CLK1-IN-1
化合物 T10836
|
2123491-32-5 | 98% |
|
CLK1-IN-1 is a potent and selective inhibitor of the Cdc2-like kinase 1 (CLK1; IC50: 2 nM). | ||||
T14915 | CDK12-IN-E9
化合物 T14915
|
2020052-55-3 | 98% |
|
CDK12-IN-E9 is a potent and selective covalent CDK12 inhibitor and non-covalent CDK9 inhibitor while avoiding ABC transporter-mediated efflux. It has a weak bind... | ||||
T10096 | (2S,3R)-Voruciclib
化合物 T10096
|
1253731-24-6 | 98% |
|
(2S,3R)-Voruciclib is the (2S,3R)-enantiomer of Voruciclib. It is an orally active CDK inhibitor. | ||||
T13696 | FN-1501-propionic acid
化合物 T13696
|
2408642-48-6 | 98% |
|
FN-1501-propionic acid, a CDK2/9 ligand, in conjunction with a CRBN ligand, has been utilized in the design of a PROTAC CDK2/9 degrader. | ||||
T22440 | TP-353
化合物TP-353
|
1253799-29-9 | 99.98% |
|
TP-353 (EOS-61973) 是一种 CDK7 抑制剂。 | ||||
T11960 | MBM-55
化合物MBM-55
|
2083622-09-5 | 99.98% |
|
MBM-55 是一种有效的中心体相关激酶 2 (NEK2) 抑制剂,IC50 为 1 nM。 MBM-55 通过诱导细胞周期停滞和凋亡有效抑制癌细胞的增殖。 | ||||
T6162 | BS-181 hydrochloride
化合物BS-181 HCl
|
1397219-81-6 | 99.97% |
|
BS-181 hydrochloride (BS-181 HCl) 是一种高度选择性的CDK7抑制剂,IC50值为 21 nM。它对 CDK7 的选择性是对 CDK1、2、4、5、6 和 9 的 40 倍以上。 |